TABLE 1.
Gene | Fold changea
|
|
---|---|---|
BM | Spleen | |
Transcription factor genes | ||
E2A | −2.2 ± 0.2 | −2.3 ± 0.2 |
EBF | −3.5 ± 1.0 | −2.2 ± 0.3 |
Pax-5 | −2.1 ± 0.2 | −2.6 ± 0.3 |
Id2 | 1.7 ± 0.2 | 3.9 ± 0.1 |
SCL | 1.4 ± 0.3 | 2.3 ± 0.1 |
PU.1 | −3 ± 0.1 | −1.5 ± 0.3 |
Spi-B | −1.7 ± 0.2 | −2.3 ± 0.2 |
LEF-1 | −3.2 ± 0.2 | −1.5 ± 0.2 |
TCF-1 | 2.6 ± 0.3 | 1.2 ± 0.6 |
B-cell-specific gene | ||
Ig-α (mb-1) | −2.1 ± 0.1 | −2.2 ± 0.2 |
Ig-β (B29) | −1.5 ± 0.3 | −1.6 ± 0.2 |
RAG-1 | −1.9 ± 0.3 | 1.8 ± 0.2 |
RAG-2 | −2.8 ± 0.3 | 1.6 ± 0.5 |
Vpre-B | −2.6 ± 0.2 | −2.4 ± 0.1 |
Lambda 5 | −2.7 ± 0.5 | −1.3 ± 0.3 |
TdT | −3.6 ± 0.2 | −1 ± 0.8 |
J chain | 4.3 ± 0.5 | 6.7 ± 2.1 |
Identical microarray experiments were performed in duplicate with CD19+ bone marrow (BM) and splenic B cells from wild-type and LMP2A transgenic mice. The average fold change in gene expression in cells from LMP2A transgenic mice versus wild-type mice from the two experiments is shown, along with the standard deviation. Negative values indicate decreased expression.